LC
HCM icon

Lindbrook Capital’s HUTCHMED HCM Stock Holding History

Lindbrook Capital’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-610
Closed -$21K – 2531
2021
Q4 		$21K Buy
610
+97
+19% +$3.15K ﹤0.01% 997
2021
Q3 		$19K Hold
513
– – 0.01% 766
2021
Q2 		$20K Sell
513
-88
-15% -$2.54K ﹤0.01% 782
2021
Q1 		$17K Hold
601
– – ﹤0.01% 809
2020
Q4 		$19K Buy
601
+5
+0.8% +$154 ﹤0.01% 700
2020
Q3 		$19K Buy
596
+17
+3% +$530 0.01% 624
2020
Q2 		$16K Buy
579
+178
+44% +$3.86K ﹤0.01% 684
2020
Q1 		$7K Buy
+401
New +$9.67K ﹤0.01% 870

Other funds holding HCM

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Lindbrook Capital's HCM Position: Q1 2022 in Review

Lindbrook Capital sold out of HUTCHMED (HCM) in Q1 2022, closing a stake of 610 shares — an estimated $21K sold.

Lindbrook Capital first reported a position in HCM in Q1 2020 and held it in 8 quarters. The position peaked at $21K in Q4 2021. 130 funds tracked by Wall St. Rank hold HCM as of Q1 2022.

  • Lindbrook Capital reported no remaining HUTCHMED position as of Q1 2022 after selling out during the quarter.
  • Lindbrook Capital sold 610 HUTCHMED shares in Q1 2022, an estimated $21K.
  • Lindbrook Capital first reported a position in HUTCHMED in Q1 2020 and held it in 8 quarters.
  • Lindbrook Capital's HUTCHMED position peaked at $21K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2022.

Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.